Brain Ischemia Drug Development Pipeline Analysis Report 2018 - ResearchAndMarkets.com

July 30, 2018

DUBLIN--(BUSINESS WIRE)--Jul 30, 2018--The “2018 Brain Ischemia Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Brain Ischemia Market” report has been added to ResearchAndMarkets.com’s offering. Brain ischemia or Cerebral ischemia condition refers to inadequate blood supply to the brain to enable it to cater its regular metabolic requirements. This can result in brain tissue death, ischemic stroke, hemorrhage, resulting in loss of movement, speech and vision difficulties, impact on memory, weakness, unconsciousness etc. Depending on the affected area in the brain, Brain Ischemia is classified as focal (certain area in the brain) and global (large portion of the brain). Analgesics, Anti- platelet drugs and BP controlling drugs are typically administered. To assist researchers, investors and business development managers, the publisher has come up with a comprehensive report on Brain Ischemia pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials. Drugs under development directly and through combination with other drugs are also included. Current status, developmental phase, participating companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Brain Ischemia pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report. In addition to complete details of each product, the report provides key trends in Brain Ischemia pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development. Companies Mentioned

Aranda Pharma Ltd Aronora Inc CohBar Inc Lixte Biotechnology Holdings NeuroNascent Inc NeurOp Inc NoNO Inc Prolong Pharmaceuticals, LLC Vect-Horus SAS

Key Topics Covered: 1 Table of Contents 2 Brain Ischemia Pipeline Analysis 3 Brain Ischemia- Company Wise Pipeline Analysis 4 Brain Ischemia R&D Pipeline Snapshots 5 Recent Developments in Brain Ischemia Pipeline 6 Appendix For more information about this report visit https://www.researchandmarkets.com/research/ddjkwk/brain_ischemia?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180730005342/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Discovery,Cardiovascular Drugs ,Clinical Trials



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/30/2018 07:27 AM/DISC: 07/30/2018 07:27 AM


Update hourly